Creative Bioarray Develops Customized Approaches of Immunohistochemistry Services to Accelerate Biological Projects


(Spin Digit Editorial):- New York City, New York Jun 28, 2022 ( – Histobiolab, the division of Creative Bioarray especially for histology research, focuses on developing a broad range of tissue processing, immunohistochemistry (IHC) and in situ hybridization services, and molecular and digital pathology to deliver consistent, high quality and reproducible results. With a well-equipped laboratory for routine and special methods in histology, Histobiolab develops advanced histological technology for testing and evaluation of tissue samples, Recently, Histobiolab announced the release of its immunohistochemistry services to accelerate biological projects.

IHC studies with optimized staining protocols for specific target expression/analysis in human and animal tissues can be used for a variety of reasons, such as proliferation/apoptosis studies, immuno-oncology, tumor analysis, and tissue cross-reactivity. Creative Bioarray has well-trained and knowledgeable staff who collaborate with researchers to provide the best way to achieve project goals, have established hundreds of antibody protocols for different species, and are continually optimizing others.

Creative Bioarray has a range of immunohistochemical markers optimized for paraffin-embedded tissue, many compatible with cryosections. Creative Bioarray offers an antibody “checkout” service to test new or untested antibodies on the tissue of interest to customers. When optimizing new antibodies, it can be helpful to discuss fixation options with a pathologist before collecting tissue. Creative Bioarray invests in innovation through fully equipped histopathology laboratories.

More on Spindigit:

In order to perform routine IHC/IF staining successfully and consistently, it is critical to develop an optimal protocol for a specific antibody. Creative Bioarray’s IHC/IF validation services have established protocols for more than 200 biomarkers spanning oncology, immunology, neuroscience, and metabolic diseases.

Creative Bioarray focuses on the optimization of qualitative IHC, where the purpose of the IHC protocol is to ensure that IHC staining clearly identifies whether the antigen is expressed in the tissue, and antibody optimization for immunohistochemistry and multiplex immunofluorescence is successful.

Creative Bioarray has a variety of tissues from various animal species. With years of combined experience in TCR research, Creative Bioarray has successfully optimized IHC analysis of multiple novel antibody types. Relying on an advanced histology technology platform and a professional technical team, Creative Bioarray can provide customers with all the services required for TCR research. In addition, Creative Bioarray provides the latest IHC detection and analysis methods and evaluates the results, helping customers quickly obtain key parameters and complete the next steps.

“Creative Bioarray provides detailed specimen data for all types of biospecimens, supports a variety of specimen formats and collection types, and provides a streamlined procurement process.” said Hannah Cole, the marketing director of Creative Bioarray, she also added, “We can also provide custom solutions to investigate the feasibility of your research project.”

About Histobiolab
As a mature division of Creative Bioarray, Histobiolab definitely will be the ideal and reliable innovation partner in research endeavors. With the support of professional scientists and years of experience, we are capable to provide a knowledgeable, collaborative and flexible service to our clients so as to accelerate drug development and improve research quality for worldwide projects.


Media Contact

Creative Bioarray

[email protected]

1 631 386 8241

Shirley, NY 11967, USA

Source :Creative Bioarray

This article was originally published by IssueWire. Read the original article here.